Login / Signup

A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.

Zisis TsourisChristos LiaskosEfthymios DardiotisThomas ScheperVana TsimourtouWolfgang MeyerGeorge HadjigeorgiouDimitrios P Bogdanos
Published in: Auto- immunity highlights (2020)
Despite the relatively frequent presence of liver autoantibodies, tested either by IF or molecular assays, overt AILD is rather infrequent discouraging autoantibody screening strategies of MS patients in the absence of clinical suspicion.
Keyphrases
  • end stage renal disease
  • systemic lupus erythematosus
  • multiple sclerosis
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • mass spectrometry
  • ms ms
  • prognostic factors
  • drug induced